FDA Investigator James R Birkenstamm
James R Birkenstamm has inspections in 4 countries as of 29 Aug 2023. James R Birkenstamm has collaborated with a combined 2746 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Germany,
United States of America,
Korea (Republic of),
Thailand
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alberto A Viciedo,
Alice S Tsao,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ankur C Patel,
Anna M Brannen,
Annemarie B Randow,
Annemarie Bodnar,
Arthur T Ogdahl,
Ashley J Burns,
Atul J Agrawal,
Barbara Jwilimczyk Macri,
Bonita S Chester,
Byungja E Marciante,
Cassandra L Abellard,
Charles I Ann,
Christopher S Keating,
Daniel J Grabicki,
Daniel J Min,
David A Oluwo,
David H Smith,
Dawn L Wydner,
Denise M Digiulio,
Denise M Visco, Investigator,
Devon Jenkins,
Dhaval H Patel,
Doreen P Gubbay,
Douglas C Kovacs,
Dr. Robert C Horan, MD,
Edward Oshaughnessy,
Elaine E Gilfillan,
Emest Bizjak,
Emest F Bizjak,
Emmanuel J Ramos,
Erika E Englund, PhD,
Ernest F Bizjack,
Esteban Beltran,
Felix Maldonado,
Frank J Marciniak,
Frederick Razzaghi,
George J Flynn,
Gianine E Tompkins,
Gobiga Vanniyasingam,
Guerlain Ulysse,
Helen Verdel,
Janet A Rajan,
Jay B Shah,
Jean Blackston Hill,
Jean Blackstone Hill,
Jennifer J Stone,
Jennifer L Custodio,
Jennifer L Huntington,
Jennifer Macmillan,
Jessica M Monteiro,
Joanne E King,
Jogy George,
John A Gonzalez,
John D White,
Johnna L Bleem,
Jonathan S Helfgott,
Jonee J Mearns,
Jose Acruz Gonzalez,
Jose M Cayuela,
Jot R Klena,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen F Tomaziefski,
Karishma G Gopaul,
Katherine Szestypalow,
Kelli F Dobilas,
Kham Phommachanh,
Ko U Min,
Kristen E Rescigno,
Kristina L Conroy,
Kristy A Zielny,
Larry K Austin,
Lata C Mathew, PhD,
Lauren L Vajo,
Lawrence Harmon, Jr,
Lenahan Lenahan, Peter R,
Liatte Kreuger, PharmD,
Lisa M Bellows,
Lisa M Feola,
Loretta Nemchik,
Lucila B Nwatu,
Luella J Rossi,
Marea K Harmon,
Margaret M Annes,
Margaret M Sands,
Maria A Bienkowski,
Maria A Reed,
Maria Estrella,
Marie Bbuen Bigornia,
Mary E Storch,
Megan A Haggerty,
Melissa T Roy,
Meredith L Sheridan,
Meyer J Slobotsky,
Michael A Charles,
Michael A Taylor,
Michael L Chasey,
Michael R Klapal,
Michael Serrano,
Miguel A Martinez,
Mihaela Jason,
Monika Borkowska,
Nancy F Scheraga,
Nancy L Rolli,
Nancy M Espinal,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Nina Yang,
Nyungja E Marciente,
Odera I Ekwunife,
Patrick C Klotzbuecher,
Paul L Bellamy,
Paul Mouris,
Peter R Lenahan,
Pushpa S Jayasekara,
Qin Xu,
Ramon A Hernandez,
Raymond L Cheung,
Rebecca Rodriguez,
Regina T Brown,
Richard J Muzeni,
Roger F Zabinski,
Rose Ljean Mary,
Russell J Glapion,
Samir C Gala,
Sandra A Hughes,
Sarah Forney,
Satheesh K Podaralla,
Sayyem H Akbar,
Sean G Casey,
Sripal R Mada, PhD,
Stephanie T Durso,
Stephen J Koniers,
Stephen J Mottola,
Steven M Weinman,
Syeda N Mahazabin,
Tamil Arasu, PhD,
Tanya R Syffrard,
Temar Q Williams,
Thomas E Friel,
Tiffani D Wilson,
Tonia F Bernard,
Unnee Ranjan,
Victoria Spivak,
William J Muszynski,
William R Chang,
Yvins Dezan
James R Birkenstamm's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more